Monday, May 18, 2009

Xori Spins Out Of Accelerator

Seattle-based XORI, a biotech startup, has spun out of Accelerator Corp.. According to Accelerator, Xori is focused on technology for the rapid discovery and development of monoclonal antibodies (MAbs). Investors in the Series A funding included Accelerator Corp., Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, PPD, and WRF Capital. The firm was founded by University of Washington professor Dr. Nancy Maizels. According to a recent regulatory filing, the funding was worth has raised $2.1M, and is part of a $4.5M funding round. More information »